FibroGen (FGEN) Tops Q1 EPS by 15c
Tweet
Share
E-mail
Get Alerts FGEN Hot Sheet
Join SI Premium – FREE
FibroGen (NASDAQ: FGEN) reported Q1 EPS of $0.05, $0.15 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $2.74 million versus the consensus estimate of $35.5 million.
For earnings history and earnings-related data on FibroGen (FGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix (NFLX) PT Lowered to $105 at BofA Securities
- F.N.B. Corp (FNB) Reports In-Line Q2 EPS
- Verizon to cut 3,000 jobs as it shifts stores to franchises
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
